SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.680
AS - Asia 12.624
EU - Europa 6.541
SA - Sud America 2.071
Continente sconosciuto - Info sul continente non disponibili 421
AF - Africa 290
OC - Oceania 18
Totale 51.645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.026
SG - Singapore 4.706
CN - Cina 3.011
BR - Brasile 1.585
VN - Vietnam 1.484
IT - Italia 1.335
UA - Ucraina 1.125
DE - Germania 1.100
HK - Hong Kong 1.074
TR - Turchia 855
GB - Regno Unito 681
FI - Finlandia 450
BD - Bangladesh 389
PL - Polonia 358
FR - Francia 357
SE - Svezia 357
RU - Federazione Russa 341
CA - Canada 270
IN - India 243
MX - Messico 214
JP - Giappone 208
AR - Argentina 163
ID - Indonesia 161
ZA - Sudafrica 92
ES - Italia 85
NL - Olanda 84
IQ - Iraq 78
CO - Colombia 74
EC - Ecuador 73
AT - Austria 56
PK - Pakistan 55
BE - Belgio 48
VE - Venezuela 48
UZ - Uzbekistan 47
CL - Cile 41
SA - Arabia Saudita 41
MA - Marocco 39
JM - Giamaica 38
LT - Lituania 35
TN - Tunisia 33
PY - Paraguay 31
PH - Filippine 29
CR - Costa Rica 27
KE - Kenya 27
IR - Iran 25
MY - Malesia 24
UY - Uruguay 23
EG - Egitto 22
CZ - Repubblica Ceca 20
ET - Etiopia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
NI - Nicaragua 16
PS - Palestinian Territory 16
HN - Honduras 15
IL - Israele 15
NP - Nepal 15
PE - Perù 15
AZ - Azerbaigian 14
KR - Corea 14
RO - Romania 14
DZ - Algeria 13
GT - Guatemala 13
SV - El Salvador 12
AL - Albania 11
BO - Bolivia 11
TT - Trinidad e Tobago 11
CH - Svizzera 10
KZ - Kazakistan 10
OM - Oman 10
TH - Thailandia 10
GR - Grecia 9
TW - Taiwan 9
NG - Nigeria 8
BB - Barbados 7
HU - Ungheria 7
LB - Libano 7
BG - Bulgaria 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
PA - Panama 6
RS - Serbia 6
DK - Danimarca 5
EE - Estonia 5
GA - Gabon 5
GD - Grenada 5
MD - Moldavia 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BM - Bermuda 4
CI - Costa d'Avorio 4
GE - Georgia 4
IE - Irlanda 4
KW - Kuwait 4
LV - Lettonia 4
LY - Libia 4
Totale 51.155
Salva come PNG Salva come JPEG
Città #
Fairfield 3.011
Ashburn 2.986
Singapore 2.936
Woodbridge 2.711
San Jose 1.681
Houston 1.615
Seattle 1.261
Jacksonville 1.249
Ann Arbor 1.194
Chandler 1.098
Hong Kong 1.052
Wilmington 998
Cambridge 997
Santa Clara 946
Beijing 893
Council Bluffs 753
Dallas 470
Ho Chi Minh City 465
Izmir 451
Los Angeles 393
Nanjing 359
Warsaw 341
Hanoi 333
New York 318
Princeton 287
Addison 248
San Diego 248
Lauterbourg 239
Ferrara 236
Milan 205
Boardman 202
Munich 202
Tokyo 196
São Paulo 153
Helsinki 140
Shanghai 127
Nanchang 119
Buffalo 118
Mexico City 116
Orem 107
Jakarta 102
London 95
Phoenix 95
Shenyang 93
Rome 92
Dearborn 91
Atlanta 84
Hebei 84
The Dalles 84
Tianjin 84
Toronto 84
Hefei 80
Chicago 76
Bremen 71
Denver 70
Turku 70
Da Nang 68
Brooklyn 67
Falls Church 65
Haiphong 61
Mountain View 59
Jiaxing 57
San Mateo 57
Frankfurt am Main 56
Johannesburg 56
Stockholm 56
Jinan 52
Rio de Janeiro 51
Changsha 50
Montreal 50
Redwood City 47
Columbus 45
Falkenstein 45
Bologna 44
Boston 44
Brussels 44
Chennai 43
San Francisco 43
Amsterdam 42
Naples 42
Moscow 41
Nuremberg 40
Tashkent 40
Guangzhou 39
Kunming 39
Mumbai 39
Belo Horizonte 38
Brasília 36
Manchester 36
Baghdad 33
Philadelphia 33
Poplar 33
Norwalk 31
Ankara 30
Dong Ket 30
Des Moines 29
Ningbo 29
Orange 28
Vienna 28
Hangzhou 27
Totale 34.732
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 295
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 285
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 285
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 276
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 275
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 270
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 265
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 264
Correlation of expression between different IMAGE clones from the same UniGene cluster 263
MicroRNA expression profiling in human Barrett's carcinogenesis. 262
MicroRNA Expression Signatures in Solid Malignancies 260
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 254
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 252
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 246
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 245
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 244
Reprogramming of miRNA networks in cancer and leukemia 242
Identification of microRNA activity by Targets' Reverse EXpression. 242
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 240
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 237
Microevolution in Ferrara: Isonymy 1890–1990 237
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 236
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 234
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 234
GAMES identifies and annotates mutations in next-generation sequencing projects 233
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 232
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 229
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 228
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 228
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 228
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 228
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 227
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 227
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 226
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 226
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 225
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 221
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 220
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 220
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 220
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 219
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 214
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 214
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 214
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 213
Espressione dei MicroRNA nei carcinomi mammari 213
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 213
TOM: Transcriptomics of OMIM. 210
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 209
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 209
CG Dinucleotides of class II MHC genes are mutation hot-spots 208
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 208
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 208
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 205
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 204
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 204
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 204
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 204
Partial gene deletion in a family with factor X deficiency 203
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 203
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 203
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 202
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 202
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 201
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 201
Modulation of mismatch repair and genomic stability by miR-155 201
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 199
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 199
Expression profiles of craniosynostosis-derived fibroblasts 197
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 196
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 195
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 194
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 194
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 194
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 194
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 193
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 192
The role of microRNA genes in papillary thyroid carcinoma 192
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 191
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 189
A microRNA expression signature of human solid tumors defines cancer gene targets 189
The network of non-coding RNAs in cancer drug resistance 186
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 186
GOAL: automated gene ontology analisys of expression profiles. 185
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 184
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 183
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 181
The network of non-coding RNAs and their molecular targets in breast cancer 180
MicroRNA profiles discriminate among colon cancer metastasis 180
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 179
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 178
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 177
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 176
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 176
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 176
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 173
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 173
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 173
Inhibition of Type 2 Transglutaminase significantly alters long noncoding RNAs expression in triplenegative breast cancer cell line. 172
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 172
Totale 21.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.530
Totale 220.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.309 0 0 0 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/202616.943 1.506 749 1.585 2.156 2.337 990 1.991 990 1.669 1.740 825 405
2026/20273.615 451 955 1.538 671 0 0 0 0 0 0 0 0
Totale 51.645